Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer drugs
Pharma
Many meds couldn't prove benefits after speedy FDA nods: study
Many cancer meds approved under the FDA's accelerated approval from 2013 to 2017 pathway didn't improve patient survival in follow-up trials.
Zoey Becker
Apr 8, 2024 6:30pm
Teva inks cancer biosimilar marketing pact with mAbxience
Apr 4, 2024 10:33am
Pfizer eyes 8 blockbuster cancer drugs in new oncology plan
Feb 29, 2024 5:42pm
Moderna's manufacturing operations reveal state of the company
Feb 22, 2024 10:15am
US WorldMeds scores FDA approval in aggressive cancer
Dec 14, 2023 4:06pm
Pharma heads for cancer first line, causing early-stage rethink
Nov 17, 2023 3:00am